Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


18.03.2019

1 BMJ
3 Clin Infect Dis
1 Clin Microbiol Rev
1 J Infect Dis
1 JAMA
2 Lancet
2 Lancet Infect Dis
1 PLoS Comput Biol
2 PLoS One
1 Proc Natl Acad Sci U S A
13 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMJ

  1. TANNE JH
    Parents of US boy who survived tetanus after nearly $1m of care refuse vaccine.
    BMJ. 2019;364:l1172.
    PubMed     Text format    


    Clin Infect Dis

  2. ROMANIN V, Acosta AM, Juarez MDV, Briere E, et al
    Maternal Vaccination in Argentina: Tdap Vaccine Effectiveness During Pregnancy in Preventing Pertussis in Infants Less Than 2 Months of Age.
    Clin Infect Dis. 2019 Mar 16. pii: 5381906. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. CHONG CR, Park VJ, Cohen B, Postow MA, et al
    Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors (ICI).
    Clin Infect Dis. 2019 Mar 15. pii: 5381697. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. LEVY C, Varon E, Ouldali N, Bechet S, et al
    Changes in invasive pneumococcal disease spectrum after 13 valent pneumococcal conjugate vaccine implementation.
    Clin Infect Dis. 2019 Mar 14. pii: 5380638. doi: 10.1093.
    PubMed     Text format     Abstract available


    Clin Microbiol Rev

  5. ZIMMERMANN P, Curtis N
    Factors That Influence the Immune Response to Vaccination.
    Clin Microbiol Rev. 2019;32.
    PubMed     Text format     Abstract available


    J Infect Dis

  6. HUYEN DTT, Mach O, Trung NT, Thai PQ, et al
    Rapid Disappearance of Poliovirus Type 2 Immunity in Young Children Following Withdrawal of Oral Poliovirus Type 2 Containing Vaccine in Vietnam.
    J Infect Dis. 2019 Mar 14. pii: 5380634. doi: 10.1093.
    PubMed     Text format     Abstract available


    JAMA

  7. ABBASI J
    Quick Uptakes: After Rotavirus Vaccine, Australia's Type 1 Diabetes Incidence Declines.
    JAMA. 2019 Mar 13. pii: 2728577. doi: 10.1001/jama.2019.0766.
    PubMed     Text format    


    Lancet

  8. WILDER-SMITH A, Ooi EE, Horstick O, Wills B, et al
    Dengue.
    Lancet. 2019;393:350-363.
    PubMed     Text format     Abstract available

  9. THE LANCET
    Canada's mandatory vaccination reporting plans.
    Lancet. 2019;393:960.
    PubMed     Text format    


    Lancet Infect Dis

  10. DONZELLI A, Duca P
    4CMenB safety and persistence of protection are unsatisfactory.
    Lancet Infect Dis. 2018;18:599-600.
    PubMed     Text format    

  11. IVERS LC
    Cholera control: one dose at a time.
    Lancet Infect Dis. 2018;18:591-592.
    PubMed     Text format    


    PLoS Comput Biol

  12. YANG W, Li J, Shaman J
    Characteristics of measles epidemics in China (1951-2004) and implications for elimination: A case study of three key locations.
    PLoS Comput Biol. 2019;15:e1006806.
    PubMed     Text format     Abstract available


    PLoS One

  13. DODD CN, de Ridder M, Huang WT, Weibel D, et al
    Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study.
    PLoS One. 2018;13:e0204799.
    PubMed     Text format     Abstract available

  14. DABRAL N, Burcham GN, Jain-Gupta N, Sriranganathan N, et al
    Overexpression of wbkF gene in Brucella abortus RB51WboA leads to increased O-polysaccharide expression and enhanced vaccine efficacy against B. abortus 2308, B. melitensis 16M, and B. suis 1330 in a murine brucellosis model.
    PLoS One. 2019;14:e0213587.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  15. STEFANETTI G, Okan N, Fink A, Gardner E, et al
    Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to Francisella tularensis.
    Proc Natl Acad Sci U S A. 2019 Mar 14. pii: 1900144116.
    PubMed     Text format     Abstract available


    Vaccine

  16. YIANNAKOULIAS N, Slavik C, Chase M
    Expressions of pro- and anti-vaccine sentiment on YouTube.
    Vaccine. 2019 Mar 9. pii: S0264-410X(19)30292.
    PubMed     Text format     Abstract available

  17. LAYTON JB, Butler AM, Brookhart MA, Panozzo CA, et al
    Variation in rotavirus vaccination coding in state US medicaid data.
    Vaccine. 2019 Mar 12. pii: S0264-410X(19)30311.
    PubMed     Text format     Abstract available

  18. MERCALDO RA, Bellan SE
    Evaluation of alternative endpoints for ZIKV vaccine efficacy trials.
    Vaccine. 2019 Mar 11. pii: S0264-410X(19)30273.
    PubMed     Text format     Abstract available

  19. THORRINGTON D, van Leeuwen E, Ramsay M, Pebody R, et al
    Assessing optimal use of the standard dose adjuvanted trivalent seasonal influenza vaccine in the elderly.
    Vaccine. 2019 Mar 11. pii: S0264-410X(19)30293.
    PubMed     Text format     Abstract available

  20. BURNY W, Marchant A, Herve C, Callegaro A, et al
    Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans.
    Vaccine. 2019 Mar 5. pii: S0264-410X(19)30209.
    PubMed     Text format     Abstract available

  21. MOUCHET J, Begaud B
    Hepatitis B vaccination and central demyelination - History, description and observed/expected analyses of 624 cases reported to the French pharmacovigilance over a 20-year period.
    Vaccine. 2019 Mar 6. pii: S0264-410X(19)30253.
    PubMed     Text format     Abstract available

  22. ZHAN Y, Deng Y, Huang B, Song Q, et al
    Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates.
    Vaccine. 2019 Mar 6. pii: S0264-410X(19)30270.
    PubMed     Text format     Abstract available

  23. FOTSO KAMDEM A, Vidal C, Pazart L, Leroux F, et al
    A case-control study of risk factors for intussusception among infants in eastern France after the introduction of the rotavirus vaccine.
    Vaccine. 2019 Mar 7. pii: S0264-410X(19)30260.
    PubMed     Text format     Abstract available

  24. TING-HUI-LIN, Chia MY, Lin CY, Yeh YQ, et al
    Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development.
    Vaccine. 2019;37:1897-1903.
    PubMed     Text format     Abstract available

  25. VERELST F, Kessels R, Delva W, Beutels P, et al
    Drivers of vaccine decision-making in South Africa: A discrete choice experiment.
    Vaccine. 2019 Mar 8. pii: S0264-410X(19)30263.
    PubMed     Text format     Abstract available

  26. SEKIYA T, Mifsud EJ, Ohno M, Nomura N, et al
    Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.
    Vaccine. 2019 Mar 8. pii: S0264-410X(19)30264.
    PubMed     Text format     Abstract available

  27. ABAASA A, Nash S, Mayanja Y, Price M, et al
    Simulated vaccine efficacy trials to estimate HIV incidence for actual vaccine clinical trials in key populations in Uganda.
    Vaccine. 2019 Mar 8. pii: S0264-410X(19)30289.
    PubMed     Text format     Abstract available

  28. JACOBS AAC, Harks F, Hazenberg L, Hoeijmakers MJH, et al
    Efficacy of a novel inactivated Lawsonia intracellularis vaccine in pigs against experimental infection and under field conditions.
    Vaccine. 2019 Mar 11. pii: S0264-410X(19)30274.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: